Harvard Management Co. Decreased Investments in Meta and Alphabet, Sold Biopharma Holdings in Q3

The Harvard Management Company sold a significant percentage of its direct holdings in Meta and Alphabet, as well as the entirety of its direct holdings in several acquired biomedical and pharmaceutical companies, during the third quarter of 2023.

Harvard Endowment Direct Public Investments

Faculty of Arts and Sciences Ends Fiscal Year 2023 with $62 Million Surplus

Harvard’s Faculty of Arts and Sciences reported a surplus of $62 million for fiscal year 2023, according to a report presented at a faculty meeting Tuesday.

FAS Consolidated Net Results By Fiscal Year

FAS Consolidated Cash Expenses By Fiscal Year

FAS Consolidated Cash Revenue By Fiscal Year

By the Numbers: Harvard’s Fiscal Year 2023 Financials

Harvard released its Annual Financial Report on Thursday, which offers a rare glimpse into the University’s finances and investment strategy. Here’s a closer look at the data revealed by this year’s disclosures.

Harvard Ended Fiscal Year 2023 with $186M Budget Surplus

Harvard ended fiscal year 2023 with a $186 million budget surplus — less than half of last year’s value — as the school faced rising costs from investments in its workforce and renewed activity on campus following the pandemic.

Harvard Endowment Value Falls For Second Consecutive Year, Records Modest 2.9% Return During FY2023

The value of Harvard’s endowment fell for the second consecutive year, despite delivering a 2.9 percent return for fiscal year 2023, as distributions to school operations outpaced investment gains and new contributions.

Harvard Operating Expenses 2023